PDF(Pubmed)
Abstract：
Interventions in structural heart disease cover many catheter-based procedures for congenital and acquired conditions including valvular diseases, septal defects, arterial or venous obstructions, and fistulas. Among the available procedures, the most common are aortic valve implantation, mitral or tricuspid valve repair/implantation, left atrial appendage occlusion, and patent foramen ovale closure. Antithrombotic therapy for transcatheter structural heart disease interventions aims to prevent thromboembolic events and reduce the risk of short-term and long-term complications. The specific approach to antithrombotic therapy depends on the type of intervention and individual patient factors. In this review, we synopsize contemporary evidence on antithrombotic therapies for structural heart disease interventions and highlight the importance of a personalized approach. These recommendations may evolve over time as new evidence emerges and clinical guidelines are updated. Therefore, it\'s crucial for healthcare professionals to stay updated on the most recent guidelines and individualize therapy based on patient-specific factors and procedural considerations.
摘要：
结构性心脏病的干预措施涵盖了许多基于导管的先天性和获得性疾病，包括瓣膜疾病，间隔缺损,动脉或静脉阻塞，还有瘘管.在可用的程序中，最常见的是主动脉瓣植入，二尖瓣或三尖瓣修复/植入,左心耳封堵术,卵圆孔未闭闭合。经导管结构性心脏病干预的抗血栓治疗旨在预防血栓栓塞事件并降低短期和长期并发症的风险。抗血栓治疗的具体方法取决于干预类型和个体患者因素。在这次审查中,我们总结了用于结构性心脏病干预的抗血栓治疗的当代证据,并强调了个性化治疗方法的重要性.随着新证据的出现和临床指南的更新，这些建议可能会随着时间的推移而发展。因此,对于医疗保健专业人员来说，保持最新指南的更新并根据患者特定因素和程序考虑个性化治疗是至关重要的。
